A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis

Journal of Vector Borne Diseases

Volumn 43, Issue 4, 2006, Pages 161-167

  Kochar, D K ^a,c   Saini, Govind ^a   Kochar, S K ^a   Sirohi, P ^a   Bumb, R A ^a   Mehta, R D ^a   Purohit, S K ^b  

^a S P MEDICAL COLLEGE   (India)

^b VETERINARY COLLEGE   (India)

^c NONE

Author keywords

Anthroponotic cutaneous leishmaniasis; Leishmania tropica; Oriental sore; Rifampicin

Indexed keywords

OMEPRAZOLE; RIFAMPICIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; LEISHMANIA TROPICA; MALE; MEDICAL ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIPROTOZOAL AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; OMEPRAZOLE; RIFAMPIN; TREATMENT OUTCOME;

EID: 33845404834     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Melby PC, Kreitzer RD, McMohan Pratt AD, Gam AA, Neval A. Cutaneous leishmaniasis: Review of 59 cases seen at the National Institute of Health. Clin Infect Dis 1992; 15: 924-37.
2. Pathak KML, Kochar DK, Kapoor M. Cutaneous leishmaniasis in Rajasthan. Ind J Anim Hlth 1990; 29: 187.
3. Lodha KR, Singh BB, Jatkar PR. Cutaneous leishmaniasis in Bikaner, Rajasthan. Ind Vet J 1971; 48: 121-3.
4. Changani SK, Purohit SK, Kalla G, Ahuja A. Diagnosis and treatment of canine and human cases of cutaneous leishmaniasis. Paper presented in II Annual Conference IAAVR, Jan 24-25. Hissar : Department of Veterinary Public Health & Epidemiology, Haryana Agricultural University, 1995; Ps11; p119.
5. Sharma MID, Suri JC, Kalra NL, Mohan K, Swami PN. Epidemiological and entomology features of an outbreak of cutaneous leishmaniasis in Bikaner (Rajasthan) during 1971. J Com Dis 1973; 5: 54-72.
6. Kalra NL. Epidemiology of cutaneous leishmaniasis and its control in India. Proc Nat Acad Sci India, 1996; 66(B): Sp1 issue.
7. Srivastava D, Vyas MCR, Joshi CK. Clinico-epidemiological study of cutaneous leishmaniasis in Bikaner (Rajasthan) J Com Dis 1987; 19: 326-31.
8. Sharma NL, Mahajan VK, Kanga A. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in Himachal Pradesh, India. Am J Trop Med Hyg 2005; 72(6): 819-24.
9. Magill AJ. Epidemiology of the leishmaniasis. Dermatol Clin 1995; 13(3): 505-23.
10. Kouimann M Maria J, Tagliana P, Verdier M, Roche JC. A case of oriental sore. Revuse de stomatologie et de chirugie maxilo faciale 1985; 86: 117-21.
11. Manson Bahr PEC. Cited by Barsky S, Storino W, Salgea K, Knapp P. Cutaneous leishmaniasis: surgical management of a case with unusual clinical and histological features. Arch Dermatol (1978); 114 (9): 1354-5.
12. Domoncos AN. Cited by Asher W, Cohen C (1977). Cutaneous leishmaniasis, inefficiency of treatment with metronidazole. Arch Dermatol 1971; 113: 1299.
13. Salim MM, Kandil E. Rifampicin in the treatment of cutaneous leishmaniasis. J Kuwait Med Assoc 1972; 6: 159-66.
14. Vasquez FR. Rifampicin in leishmaniasis. Arch Dermatol 1977; 113: 1610-11.
15. Dogra J, Saxena VN. Itraconazole and leishmaniasis a randomize double blind trial in cutaneous disease. Int J Parasitol 1996; 26(12): 1413-5.
16. Kochar DK, Aseri S, Sharma BV, Bumb RA, Mehta RD, Purohit SK. The role of rifampicin in the management of cutaneous leishmaniasis. Qtly J Med 2000; 93: 733-7.
17. Goldsmith RS. Current medial diagnosis and treatment, 39 edn. Infectious disease. Protozoal and Helminthic Leishmaniasis 2000; p. 1412-5.
18. Tina SSA, Timothy MED, Linda SM, Wayne AJ. The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1997; 91: 580-4.
19. + antiporter involved in glucose symport. Studies with sealed ghosts and vesicles of opposite polarity. J Biol Chem 2001; 276(8): 5563-9.
20. th edn. McGraw Hill Inc. 1998; 1189-93.
21. Seaton RA, Morrison J, Man I, Watson J. Nathwani D. Out patient parenteral antimicrobial therapy - a viable option for the management of cutaneous leishmaniasis. Qtly J Med 1999; 92: 659-67.
22. Beltran F, Gutierrez M, Biagi F. Utility du metronidazole dans le traitement de la leishmaniso cutaance mexicaine. Bull Soc Pathol Erot 1967; 60: 61-4.
23. Grissiths WA, M. Use of metronidazole in cutaneous leishmaniasis. Arch Dermatol 1976; 112(12): 1791.
24. Belazzoug S, Ammar Khodja A, Belkaid M, Tabet Derraz O. Cutaneous leishmaniasis in northern Algeria. Bull Soc Pathol Exot Filiale 1985; 78: 615-22.
25. Singh S, Singh R, Sunder S. Failure of ketoconarole in oriental sore in India. J Chemother 1996; 4: 202-3.
26. Weinrauch L, Livshin R, El On J. Ketoconazole in cutaneous leishmaniasis. Br J Dermatol 1987; 117: 666-8.
27. Ozgoztasi O, Baydar I. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int J Dermatol 1997; 36: 61-3.
28. Bygbjerg IC, Knudsen L, Kieffer M. Failure of rifampicin therapy to cure cutaneous leishmaniasis. Arch Dermatol 1980; 116: 988.